NO20081377L - Farmasoytiske preparater med regulert frigivelse for syrelabile legemidler - Google Patents

Farmasoytiske preparater med regulert frigivelse for syrelabile legemidler

Info

Publication number
NO20081377L
NO20081377L NO20081377A NO20081377A NO20081377L NO 20081377 L NO20081377 L NO 20081377L NO 20081377 A NO20081377 A NO 20081377A NO 20081377 A NO20081377 A NO 20081377A NO 20081377 L NO20081377 L NO 20081377L
Authority
NO
Norway
Prior art keywords
acid
controlled
pharmaceutical preparations
release pharmaceutical
labile drugs
Prior art date
Application number
NO20081377A
Other languages
English (en)
Other versions
NO342633B1 (no
Inventor
Claus-Juergen Koelln
George Shlieout
Frithjof Sczesny
Jens Onken
Andreas Koerner
Original Assignee
Abbott Lab Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37415587&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081377(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2006/065311 external-priority patent/WO2007020259A2/en
Application filed by Abbott Lab Gmbh filed Critical Abbott Lab Gmbh
Publication of NO20081377L publication Critical patent/NO20081377L/no
Publication of NO342633B1 publication Critical patent/NO342633B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En enterisk belagt oral doseringsform som omfatter en syrelabil, aktiv farmasøytisk bestanddel, hvor preparatet er i det vesentlige fri for monomere ftalsyreestere og syntetiske oljer, er beskrevet her. Det er også tilveiebrakt fremgangsmåter for fremstilling og anvendelse av den enterisk belagte orale doseringsform. De beskrevne farmasøytiske preparater omfatter et enterisk belegg som inkluderer minst én mykner, minst ett flimdannende middel og eventuelt minst ett antiklebemiddel.
NO20081377A 2005-08-15 2008-03-14 Farmasøytiske preparater med regulert frigivelse for syrelabile legemidler NO342633B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70869205P 2005-08-15 2005-08-15
EP05107472 2005-08-15
PCT/EP2006/065311 WO2007020259A2 (en) 2005-08-15 2006-08-15 Controlled release pharmaceutical compositions for acid labile drugs

Publications (2)

Publication Number Publication Date
NO20081377L true NO20081377L (no) 2008-05-14
NO342633B1 NO342633B1 (no) 2018-06-25

Family

ID=37415587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081377A NO342633B1 (no) 2005-08-15 2008-03-14 Farmasøytiske preparater med regulert frigivelse for syrelabile legemidler

Country Status (6)

Country Link
KR (1) KR101344546B1 (no)
DE (1) DE602006012346D1 (no)
HK (1) HK1121037A1 (no)
HR (1) HRP20100269T4 (no)
IL (1) IL189456A (no)
NO (1) NO342633B1 (no)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
JP3611456B2 (ja) * 1997-09-30 2005-01-19 日研化学株式会社 テオフィリン徐放性錠剤
KR19990072826A (ko) * 1998-02-26 1999-09-27 우재영 판크레아틴장용코팅과립의제조방법
IT1319655B1 (it) * 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.

Also Published As

Publication number Publication date
KR20080034515A (ko) 2008-04-21
IL189456A0 (en) 2008-06-05
NO342633B1 (no) 2018-06-25
IL189456A (en) 2015-11-30
KR101344546B1 (ko) 2013-12-26
DE602006012346D1 (de) 2010-04-01
HK1121037A1 (en) 2009-04-17
HRP20100269T4 (hr) 2017-06-30
HRP20100269T1 (en) 2010-06-30

Similar Documents

Publication Publication Date Title
DK1931316T3 (da) Farmaceutiske sammensætninger med kontrolleret afgivelse til syrelabile lægemidler
CY1121350T1 (el) Απο του στοματος φαρμακοτεχνικες μορφες αναλογων κυτιδινης και μεθοδοι χρησης αυτων
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
EA201291089A1 (ru) Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
NO20065638L (no) Formuleringer med kontrollert frigivelse inneholdende vardenafil
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
NO20081919L (no) Farmasoytiske preparater for behandling av forstyrrelser i det indre oret
EA200971081A1 (ru) Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
HRP20050544A2 (en) Solid drug for oral use
CO5590918A2 (es) Formulaciones
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
PT1140031E (pt) Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa
MX2021004457A (es) Composicion farmaceutica para administracion oral que comprende derivado de aminopirimidina o su sal.
NO20071806L (no) Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel.
NO20071485L (no) Kjemiske substanser.
BRPI0618370A2 (pt) formulação aerossol de medicamento, uso do mesmo e kit de inalação
BR112022009533A2 (pt) Composição farmacêutica para administração oral, e, método para preparar uma composição farmacêutica
DE602006012962D1 (de) Pharmazeutische Zubereitungen von Ciprofloxacin
NO20081377L (no) Farmasoytiske preparater med regulert frigivelse for syrelabile legemidler
RU2011113733A (ru) Производные 1-амино-алкилциклогексана для лечения когнитивного нарушения при шуме в ушах
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ABBOTT LABORATORIES GMBH, DE